Condition
Iridocyclitis
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03753893Completed
Ocular Manifestations in Rheumatic Diseases
NCT00006188Completed
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
NCT00476593Not ApplicableCompleted
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
Showing all 3 trials